NEW YORK, Nov. 4 (GenomeWeb News) - Zyomyx said today that the National Eye Institute of the National Institutes of Health would use the Zyomyx Protein Profiling Biochip System for its research into ocular disease.

NEI will use the system to study inflammatory, autoimmune, and other diseases of the eye.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.